10-K Decoder · All companies

Gyre Therapeutics, Inc.

GYRE · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$117M$106M+10.2%
Operating income$11.5M$16.2M−28.9%
Net income$5.03M$12.1M−58.4%

Questions

What was Gyre Therapeutics's revenue in FY2025?
$117M in FY2025 (Fiscal year ended Dec 31, 2025), +10.2% vs $106M a year earlier, per its 10-K filed Mar 2026.
Was Gyre Therapeutics profitable in FY2025?
Yes: net income was $5.03M and operating income $11.5M in FY2025.